This article was reported by The Washington Post.
The Washington Post reported that US health officials recently advised healthy individuals at risk of HIV to take a daily dose of the drug Truvada, which cuts the risk of infection by more than 90 percent. CDC recently provided the first formal recommendation on Truvada use as a preventive. CDC recommends the drug for individuals with HIV-positive partners and those who inject illicit drugs and share drug-injecting equipment, to prevent HIV infection. CDC also included in this recommendation heterosexual men or women who have unprotected sex with at-risk partners and gay or bisexual men who have unprotected sex or are not in a mutually monogamous relationship with an uninfected partner.
According to Jonathan Mermin, director of CDC's National Center for HIV/AIDS Prevention, with no imminent vaccine or cure for the disease, "prevention is key." Truvada as pre-exposure prophylaxis is one way of preventing HIV, which causes 50,000 new infections in the United States each year. The US Food and Drug Administration approved Gilead's Truvada for sale in 2012 to be used as part of a prevention regimen including safe sex and regular HIV testing.